J0164 HCPCS Level II code: Injection, epinephrine in sodium chloride (baxter), 0.1 mg
J0164 is the HCPCS code for “Injection, epinephrine in sodium chloride (baxter), 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg
Short description: Epinephrine in nacl (baxter)
HCPCS · United States
Medicare details
The indicators CMS publishes with J0164 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Oct 1, 2025
Where J0164 sits
- 1J codesDrugs administered other than orally
- 2Active code J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0164 mean?
J0164 is the HCPCS code for “Injection, epinephrine in sodium chloride (baxter), 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0164?
CMS lists J0164’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0164
All J codesJ0139Injection, adalimumab, 1 mgJ0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mgJ0163Injection, epinephrine in sodium chloride (endo), 0.1 mgJ0165Injection, epinephrine, not otherwise specified, 0.1 mgJ0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mgJ0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mgJ0168Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mgJ0169Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mgJ0171Injection, adrenalin, epinephrine, 0.1 mg